![Maninder Hora](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maninder Hora
Directeur Technique/Scientifique/R&D chez
VIR BIOTECHNOLOGY, INC.
Profil
Dr. Maninder Hora is a Chief Technical Operations Officer & Executive VP at Vir Biotechnology, Inc. Dr. Hora was previously employed as a Chief Technical Operations Officer by Amunix Pharmaceuticals, Inc., a Chief Technical Operations Officer by Nektar Therapeutics, a Vice President-Product Operations & Quality by Abbott Biotherapeutics Corp., a Vice President-Product Operations by PDL BioPharma, Inc., a Vice President-Process & Product Development by Chiron Corp., a Vice President by GSK Plc, a Vice President-Process & Product Development by Novartis Pharmaceuticals Corp., and a Vice President by Wyeth Pharmaceuticals LLC.
He received his undergraduate degree from Rani Durgavati University and a doctorate degree from Indian Institute of Technology New Delhi.
Postes actifs de Maninder Hora
| Sociétés | Poste | Début |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Directeur Technique/Scientifique/R&D | 27/02/2025 |
Anciens postes connus de Maninder Hora
| Sociétés | Poste | Fin |
|---|---|---|
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Directeur des opérations | 01/11/2023 |
| NEKTAR THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/06/2019 |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Corporate Officer/Principal | 01/07/2010 |
| PDL BIOPHARMA, INC. | Corporate Officer/Principal | 01/12/2008 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | 01/05/2006 |
Formation de Maninder Hora
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Indian Institute of Technology New Delhi
 Indian Institute of Technology New Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Rani Durgavati University
 Rani Durgavati University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Health Technology |
Choisissez Zonebourse 
